DB18662InvestigationalGene Therapies
Rugonersen is a locked nucleic acid antisense oligonucleotide under investigation for the treatment of Angelman Syndrome.
- Code names
- RG6091 · RO7248824 · RO-7248824-000 · RTR-33090 · RTR33090 free acid
Resolves to
Compound
What you can answer from here — as of August 04, 2026
Which companies are running trials of Rugonersen, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account